Infections caused by carbapenem-resistant Klebsiella pneumoniae among patients in intensive care units in Greece: a multi-centre study on clinical outcome.

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
L. S. Tzouvelekis, A. Markogiannakis, E. Piperaki, M. Souli, G. L
L. Boyanova  Clinical Microbiology and Infection 
Bloodstream infections among carriers of carbapenem-resistant Klebsiella pneumoniae: etiology, incidence and predictors  S. Amit, H. Mishali, T. Kotlovsky,
Changes in antimicrobial resistance, serotypes and genotypes in Streptococcus pneumoniae over a 30-year period  J. Liñares, C. Ardanuy, R. Pallares, A.
Gut bacterial microbiota and obesity
Approach to diagnosis of infective endocarditis
Molecular characterization of methicillin-resistant Staphylococcus aureus isolated over a 2-year period in a Qatari hospital from multinational patients 
P. Clarke, S. Murchan, E.G. Smyth, H. Humphreys 
Herpes zoster in non-hospitalized children
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
Candida glabrata fungaemia in intensive care units
Virological tools to diagnose and monitor hepatitis C virus infection
Outcome of carbapenem resistant Klebsiella pneumoniae bloodstream infections  D. Ben-David, R. Kordevani, N. Keller, I. Tal, A. Marzel, O. Gal-Mor, Y.
R. Cantón  Clinical Microbiology and Infection 
Chlamydia trachomatis infections in heterosexuals attending sexually transmitted disease clinics in Slovenia  D. Kese, M. Maticic, M. Potocnik  Clinical.
E. Braun, K. Hussein, Y. Geffen, G. Rabino, Y. Bar-Lavie, M. Paul 
Klebsiella pneumoniae: development of a mixed population of carbapenem and tigecycline resistance during antimicrobial therapy in a kidney transplant.
Analysis of intracellular human immunodeficiency virus (HIV)-1 drug resistance mutations in multi-failed HIV-1-infected patients treated with a salvage.
Vector control: a cornerstone in the malaria elimination campaign
Sofie Arens, Jan Verhaegen, Ludo Verbist 
G. Höffken  Clinical Microbiology and Infection 
Community-acquired pneumonia: the evolving challenge
Performance of hepatitis C virus (HCV) direct-acting antivirals in clinical trials and daily practice  J.E. Arends, P.A.M. Kracht, A.I.M. Hoepelman  Clinical.
Early invasive fungal infections and colonization in patients with cirrhosis admitted to the intensive care unit  E. Theocharidou, B. Agarwal, G. Jeffrey,
Elements of design: the knowledge on which we build
Changes in macrolide resistance among respiratory pathogens after decreased erythromycin consumption in Taiwan  P.-R. Hsueh, J.-M. Shyr, J.-J. Wu  Clinical.
Levofloxacin in the treatment of ventilator-associated pneumonia
R. Bitterman, M. Paul, D. Polak, Y. Geffen 
P. Sidira, H.C. Maltezou, A.-B. Haidich, A. Papa 
Combating the spread of carbapenemases in Enterobacteriaceae: a battle that infection prevention should not lose  P. Savard, T.M. Perl  Clinical Microbiology.
Metagenomics and probiotics
W. -L. Yu, M. -F. Lee, H. -J. Tang, M. -C. Chang, J
Impact of carbapenem resistance on clinical and economic outcomes among patients with Acinetobacter baumannii infection in Colombia  E.V. Lemos, F.P.
Klebsiella pneumoniae: development of a mixed population of carbapenem and tigecycline resistance during antimicrobial therapy in a kidney transplant.
Continuous high-dose vancomycin combination therapy for methicillin-resistant staphylococcal prosthetic hip infection: a prospective cohort study  V.
J. Garau  Clinical Microbiology and Infection 
T.M. File  Clinical Microbiology and Infection 
Update on antifungal resistance in Aspergillus and Candida
Harmonised monitoring of antimicrobial resistance in Salmonella and Campylobacter isolates from food animals in the European Union  S. Bronzwaer  Clinical.
Antibacterial drug discovery in the 21st century
Community-acquired pneumonia: epidemiologic and clinical consideration
Pandemic lineages of extraintestinal pathogenic Escherichia coli
Effect of metronidazole versus standard care on length of stay of patients admitted with severe infectious mononucleosis: a randomized controlled trial 
Molecular epidemiology and virulence factors of pyogenic liver abscess causing Klebsiella pneumoniae in China  Y. Luo, Y. Wang, L. Ye, J. Yang  Clinical.
Evolving problems with resistant pathogens
A novel fluorescence in situ hybridization test for rapid pathogen identification in positive blood cultures  A. Makristathis, S. Riss, A.M. Hirschl 
Current experience in treating invasive zygomycosis with posaconazole
Circulation of international clones of levofloxacin non-susceptible Streptococcus pneumoniae in Taiwan  Y.-C. Hsieh, L.-Y. Chang, Y.-C. Huang, H.-C. Lin,
Correlation between time to positivity of blood cultures with clinical presentation and outcomes in patients with Klebsiella pneumoniae bacteraemia: prospective.
Statin use and clinical outcomes among pneumonia patients
Clinical Microbiology and Infection
Carbapenemase-producing Klebsiella pneumoniae: (when) might we still consider treating with carbapenems?  G.L. Daikos, A. Markogiannakis  Clinical Microbiology.
Management of nosocomial pneumonia on a medical ward: a comparative study of outcomes and costs of invasive procedures  B. Herer, C. Fuhrman, Z. Gazevic,
The atypical pneumonias: clinical diagnosis and importance
J.J. Keller, M.-C. Tsai, C.-C. Lin, Y.-C. Lin, H.-C. Lin 
Abstracts Clinical Microbiology and Infection
Modelling during an emergency: the 2009 H1N1 influenza pandemic
A. Manzur, F. Gudiol  Clinical Microbiology and Infection 
Risk-factors and predictors of mortality in patients colonised with vancomycin-resistant enterococci  V. Sakka, S. Tsiodras, L. Galani, A. Antoniadou,
O. Megged, A.M. Yinnon, D. Raveh, B. Rudensky, Y. Schlesinger 
B.A. Cunha  Clinical Microbiology and Infection 
Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group†   H. Goossens  Clinical.
J.L. Balcázar  Clinical Microbiology and Infection 
G.C. Schito  Clinical Microbiology and Infection 
New patterns of HIV-1 resistance during HAART
Joshua P. Metlay, Daniel E. Singer  Clinical Microbiology and Infection 
Impact of antibiotic restrictions: the patient's perspective
The future of diagnostic bacteriology
Presentation transcript:

Infections caused by carbapenem-resistant Klebsiella pneumoniae among patients in intensive care units in Greece: a multi-centre study on clinical outcome and therapeutic options  F. Kontopidou, H. Giamarellou, P. Katerelos, A. Maragos, I. Kioumis, E. Trikka-Graphakos, C. Valakis, H.C. Maltezou  Clinical Microbiology and Infection  Volume 20, Issue 2, Pages O117-O123 (February 2014) DOI: 10.1111/1469-0691.12341 Copyright © 2014 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 1 Outcome of patients by administered antimicrobial treatment (n = 127 cases). *Twenty infections were treated with a combination regimen including carbapenems. Only in one case was the pathogen MIC <4 μg/dL. Clinical Microbiology and Infection 2014 20, O117-O123DOI: (10.1111/1469-0691.12341) Copyright © 2014 European Society of Clinical Infectious Diseases Terms and Conditions